Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy

Journal of Cutaneous Pathology

Volumn 26, Issue 2, 1999, Pages 95-100

  Crowson, A N ^a   Magro, C M ^b,c  

^a Misericordia Health Centre   (Canada)

^b Ameripath Cutaneous Pathology and Immunofluorescence   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; HISTONE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DERMATITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LICHEN PLANUS; LICHENOID; LYMPHOCYTOSIS; MALE; MICROSCOPY; MUCINOSIS; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LICHENOID ERUPTIONS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0032978717     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1999.tb01809.x     Document Type: Article

References (36)

1. Stricker BHCH, Van Dijke CHP, Isaacs AJ, Lindquist M. Skin reactions to terfenadine. Br Med J 1986; 293: 536.
2. Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol 1982; 118: 253.
3. Merrett AC, Marks R, Dudley FJ. Cimetidine-induced erytham annulare centrifugum: no cross-sensitivity with ranitidine. Br Med J 1981; 283: 698.
4. Hadfield WA Jr. Cimetidine and giant urticaria. Ann Intern Med 1979; 91: 128.
5. Angelini G, Bovo P, Vaona B, Cavallini G. Cimetidine and erythrosis-like lesions. Br Med J 1979; 1: 1147.
6. Kanwar A, Majid A, Garg MP, Singh G. Seborrheic dermatitis-like eruption caused by cimetidine. Arch Dermatol 1981; 117: 65.
7. Vircburger MI, Prelevic GM, Brkic S, et al. Transitory alopecia and hypergonadotrophic hypogonadism during cimetidine treatment. Lancet 1981; 1: 1160.
8. Dernbach WK, Taylor G. Leukocytoclastic vasculitis from cimetidine. JAMA 1981; 246: 331.
9. Ahmed AH, McLarty DG, Sharma SK, Masawe AEJ. Stevens-Johnson syndrome during treatment with cimetidine. Lancet 1978; 2: 433.
10. Yantis PL, Bridges ME, Pittman FE. Cimetidine-induced exfoliative dermatitis. Dig Dis Sci 1980; 25: 73.
11. Griffiths WAD, Peachey RDG. Fixed drug eruption due to cyclizine. Br J Dermatol 1970; 82: 616.
12. Horiuchi Y, Katagiri T. Lichenoid eruptions due to the H-2 receptor antagonists roxatidine and ranitidine [Letter]. J Dermatol 1996; 23: 510.
13. Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid infiltrates. J Am Acad Dermatol 1995; 32: 419.
14. Crowson AN, Magro CM. Antidepressant therapy: A possible cause of atypical cutaneous lymphoid hyperplasia. Arch Dermatol 1995; 131: 925.
15. Mavglit GM. Immunological side-effects of cimetidine: potential uses. Pharmacotherapy 1987; 7(Suppl 2): 120S.
16. Davidson BJ, Gilliam JN, Lipsky PE. Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med 1982; 142: 166.
17. Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia. Ann Int Med 1979; 91: 317.
18. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115: 1409.
19. David-Bajar KM. Subacute cutaneous lupus erythematosus. J Invest Dermatol 1993; 100: 2S.
20. Magro CM, Crowson AN, Harrist TJ. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol 1996; 134: 855.
21. Suys E, De Coninck A, De Pauw I, Roseeuw D. Lichen planus induced by flunarazine. Dermatologica 1990; 181: 71.
22. Crowson AN, Magro CM. Drug eruptions. In: Barnhill R, Crowson AN, Busam K, Granter S, eds. Textbook of Dermatopathology. New York: McGraw-Hill, 1998; 257.
23. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus in association with Diltiazem. New Engl J Med 1995; 33: 1429.
24. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus in the setting of calcium channel blocker therapy. Hum Pathol 1997; 28: 67.
25. Reed BR, Huff JC, Jones SK, et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 1985; 103: 49.
26. 1C) that regulate cell proliferation. Adv Biosciences 1993; 89: 31.
27. Brandes IJ, Arron RJ, Bogdanovic RP, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992; 52: 3796.
28. Brandes LJ, LaBella FS, Warrington RC. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists. J Natl Cancer Inst 1991; 83: 1329.
29. Bluming A, Homer S, Khiroya R. Selective diphenylhydantoin-induced suppression of lymphocyte reactivity in vitro. J Lab Clin Med 1976; 88: 417.
30. Dosch H-M, Jason J, Gelfand EW. Transient antibody deficiency and abnormal T-suppressor cells induced by phenytoin. N Engl J Med 1982; 306: 406.
31. Rosenthal CJ, Noguera CR, Coppola A, Kapelner SN. Pseudolymphoma with mycosis fungoides manifestions, hyperresponsiveness to diphenylhydantoin and lymphocyte disregulation. Cancer 1982; 49: 2305.
32. Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid hyperplasia: a hypothesis. Hum Pathol 1996; 27: 125.
33. Weir MR, Peppler R, Gomolka D, Handwerger BS. Additive inhibitory effect of cyclosporin and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel. Transplant Proc 1989; 21: 866.
34. McMillen MA, Lewis T, Jaffe BM, Wait RB. Verapamil inhibition of lymphocyte proliferation and function in vitro. J Surg Res 1985; 39: 76.
35. Behan PO, Behan WMH, Zacharias FJ, Nichols JT. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet 1976; 2: 984.
36. Doric M, Gligora M. Further possibilities of using aryloxycarbonic acid derivatives in clinical practice. Folia Biol (Praha) 1991; 37: 131.